ANTI-ATP13A2 (C-TERMINAL)

Description General description ATP13A2 is a member of the P5 family of ATPases which function in the transport of inorganic cations. ATPase type 13 A2 (ATP13A2), also known as Parkinson′s disease 9 (PARK9), codes for P-type ATPase that is present on the lysosomal membrane with ten transmembrane domains. Application Anti-ATP13A2 (C-terminal) antibody produced in rabbit has also been used in immunohistochemistry. Rabbit Anti-ATP13A2 (C-terminal) antibody has be used for immunofluorescence and western blotting assays. Physical form Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide. Disclaimer Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. Biochem/physiol Actions ATPase type 13A2 (ATP13A2) plays a vital role in regulation of mitochondrial bioenergetics by macroautophagy. Mutations in the ATP13A2 gene leads to the development of hereditary form of Parkinson associated with dementia, known as Kufor-Rakeb syndrome (KRS).